COMPANY
Zymo Research Corp.
Funding and NIH signals
- NIH award NIH awarded $908K (STTR Phase II 5R42NS098918-06, continuation, notice Aug 11, 2026). NIH RePORTER 5R42NS098918-06 (Aug 11, 2026)
Evidence (1 event)
- Aug 11, 2026 · NIH RePORTER 5R42NS098918-06
Organization: ZYMO RESEARCH CORPORATION; City/State: IRVINE, CA; Project number: 5R42NS098918-06; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-11; FY total cost (award amount): 907735; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: A Novel Xenon Delivery Platform for Cerebroprotection During Stroke; Organization type: Domestic For-Profits
- Aug 11, 2026 · NIH RePORTER 5R42NS098918-06
Timeline
- Grant Government grant — STTR: $907,735 (annual award, as published), announced Aug 11, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — STTR: $980,725 (annual award, as published), announced Aug 6, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Funding
- Government grant — STTR: $907,735 (annual award, as published), announced Aug 11, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Government grant — STTR: $980,725 (annual award, as published), announced Aug 6, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
NIH awards 4
- NIH award 2R42NS098918-04 FY2024: $631,721 awarded for that fiscal year; activity R42 (STTR); PI BOOHER, KEITH; recipient as written: ZYMO RESEARCH CORPORATION, IRVINE, CA. A Novel Xenon Delivery Platform for Cerebro source ↗
- NIH award 5R42NS098918-03 FY2022: $841,419 awarded for that fiscal year; activity R42 (STTR); PI BOOHER, KEITH; recipient as written: ZYMO RESEARCH CORPORATION, IRVINE, CA. Epigenetic Markers and Sustained Cytoprotec source ↗
- NIH award 2R42NS098918-02A1 FY2021: $1,082,714 awarded for that fiscal year; activity R42 (STTR); PI BOOHER, KEITH; recipient as written: ZYMO RESEARCH CORPORATION, IRVINE, CA. Epigenetic Markers and Sustained Cytopr source ↗
- NIH award 1R41NS098918-01A1 FY2017: $225,000 awarded for that fiscal year; activity R41 (STTR); PI BOOHER, KEITH; recipient as written: ZYMO RESEARCH CORPORATION, IRVINE, CA. Epigenetic Markers and Sustained Cytoprot source ↗